JPRN-UMIN000001594未知1 期
Phase I trial to assess safety and pharmacokinetics of Gefitinib plus S-1 combination therapy in patients with advanced adenocarcinoma lung - Phase I trial of Gefitinib plus S-1 combination therapy for advanced adenocarcinoma of the lung
Kinki University School of Medicine0 个研究点目标入组 20 人开始时间: 2008年12月22日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Phase I/II trial for safety and pharmacokinetics of ENDOPIN in healthy adults and patients with paiPhase 1 part: Healthy adult male Phase 2 part: Postoperative pain patientspostoperative painD010149JPRN-jRCT2051220144akajima Takako46
招募中
1 期
PedMAb1HIV/AIDSPACTR202205715278722South African Medical Research Council72
已完成
不适用
Phase 1 study to evaluate safety and pharmacokinetic property of DNP001 in patients with JL1 postive acute leukemia or myelodysplastic syndromeKCT0002421Asan Medical Center18
进行中（未招募）
1 期
Phase 1 Trial of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Activity of RP-1664 in Participants with Advanced Solid TumorsAdvanced Solid TumorsMedDRA version: 21.1Level: LLTClassification code: 10065252Term: Solid tumor Class: 10029104CTIS2024-511259-16-00Repare Therapeutics USA Inc.80
已完成
1 期
Safety, efficacy and pharmacokinetic study of paclitaxel injection concentrate for nano-dispersion in subjects with metastatic breast cancer.CTRI/2009/091/000262Sun Pharma Advanced Research Company Ltd36